Newsletter | May 25, 2023

05.25.23 -- The Potential Of Prime Editing

Featured Editorial
Industry Insights
CRISPR RNPs And The Future Of Cell And Gene Therapy

Explore the potential of ribonucleoprotein (RNP) to deliver CRISPR materials more accurately, efficiently, and effectively, as well as the manufacturing challenges which require further attention.

Freeze/Thaw And Cold Chain Process Optimization

Freezing biologics is a complex undertaking. As more biotherapies enter the market, ensuring manufacturers have the technology to optimize their cold chain applications is paramount.

5 Things To Look Out For In Cell Therapy Supply Chain

How to navigate global supply chain challenges to help avoid cell therapy manufacturing production bottlenecks this year.

Overcome Single-Use Customization Misconceptions

Single-use strategies and tools are constantly evolving to better serve industry needs, and adept solutions providers can help streamline development with simple, custom adaptations.

The Roles Of Operational Readiness, Capital Projects In Drug Manufacturing

Read more about what a facility needs to achieve operational readiness and the necessary steps to take to be at full scale production when the “go” button is hit.

Navigating The Unique Challenges Of LVV During Upstream Processing

LVVs are emerging as an indispensable tool for gene therapy, but they present significant complications for purification and concentration. Technological advancements and method optimization can help developers navigate these hurdles.

NK Cells And The Next Generation Of Adoptive Immunotherapies

Experts discuss several ways in which natural killer (NK) cells can offer a path forward as a deliver platform for engineered cell (and ex vivo gene) therapy. Explore four different aspects of cytotoxic cell therapy.

Importance Of Data Reproducibility For Developing Safe Gene Therapies

What are viral-based vectors and why are reproducible quantitation of gene expression important in gene therapy? Explore these questions through a demonstration of well-to-well and instrument-to-instrument data concordance across biosystems.

Distribution Of The First Commercial CAR-T Therapy From USA To Japan

Examine the first commercial live shipment of temperature-critical autologous final CAR-T drug product from a U.S. manufacturing site to a hospital in Japan.

mRNA Manufacturing Workflow

Therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. Learn more about key objectives, considerations, and strategies in mRNA manufacturing.

Successful Clinical Manufacturing Of Cell And Gene Therapies

While biotech companies face pressure to rush to trials, development still requires a significant amount of work. This panel explores the pitfalls for developers and indicators of GMP readiness.

Forge A Successful CRISPR Therapeutic Path With High-Quality GMP sgRNA

Learn how to accelerate your clinical timeline for cell and gene therapies and improve next-generation GMP production facilities.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.